US Biotech Wins Battle Against Europeans Over Gene Patent

ft.com — Myriad Genetics, after almost a decade, has won back the right to a key patent on a gene whose presence says a woman has inherited a significant risk of developing breast and ovarian cancer. In imposing its patents in Europe, the company insisted DNA be sent to Utah for testing. The company was accused of assault on privacy and assault on science.